Jul 2 2011
"As WHO prepares for reform, it is also adjusting to a new financially constrained environment. WHO's STOP TB department, like others, has to downsize and refocus its activities. With increasing demand for guidance, technical support, and capacity-building in countries, the STOP TB department and partnership will have to do more with less in the future," a Lancet editorial states.
"As tuberculosis enters a new era, with promising new diagnostic approaches and drugs, WHO's role will be crucial. But there is also an opportunity to broaden the global response and engage with other partners more effectively in much the same way as the HIV/AIDS community has done successfully. … If the next phase of the epidemic is to be truly different, so too must be the organisational response. A status quo in tuberculosis control is unacceptable," the editorial concludes (7/2).
 This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.
|
Leveraging cancer therapies to combat tuberculosis